Pooled screening of CAR T cells identifies diverse immune signaling domains for next-generation immunotherapies
{{output}}
Chimeric antigen receptors (CARs) repurpose natural signaling components to retarget T cells to refractory cancers but have shown limited efficacy in persistent, recurrent malignancies. Here, we introduce "CAR Pooling," a multiplexed approach to rapidly identi... ...
